GP
GSK plc Portfolio holdings
AUM
$799M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$799M
AUM Growth
–
Holding
15
Top Buys
| 1 | +$193M | |
| 2 | +$185M | |
| 3 | +$89.6M | |
| 4 |
Vir Biotechnology
VIR
|
+$50.9M |
| 5 |
IDEAYA Biosciences
IDYA
|
+$42.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Wave Life Sciences
WVE
$1.37B
| $310M | 38.82% |
+18,245,691
|
|
||
2
CRISPR Therapeutics
CRSP
$5.26B
| $169M | 21.14% |
+3,220,627
|
|
||
3
BioNTech
BNTX
$24.5B
| $84.7M | 10.6% |
+889,824
|
|
||
|
4
Vir Biotechnology
VIR
$1.49B
| $51.6M | 6.45% |
+8,550,954
|
|
||
5
Lyell Immunopharma
LYEL
$579M
| $46.6M | 5.83% |
+1,512,659
|
|
||
|
6
IDEAYA Biosciences
IDYA
$2.88B
| $46.1M | 5.77% |
+1,333,333
|
|
||
7
Cytokinetics
CYTK
$8.22B
| $21.6M | 2.71% |
+340,434
|
|
||
8
Spero Therapeutics
SPRO
$161M
| $21.4M | 2.68% |
+9,190,606
|
|
||
9
Fulcrum Therapeutics
FULC
$515M
| $20.2M | 2.53% |
+1,785,714
|
|
||
|
BCYC
10
Bicycle Therapeutics
BCYC
$347M
| $10.8M | 1.36% |
+1,529,561
|
|
||
11
CVRx
CVRX
$205M
| $7.15M | 0.9% |
+1,007,583
|
|
||
12
Nkarta
NKTX
$163M
| $5.83M | 0.73% |
+3,150,732
|
|
||
13
Regenxbio
RGNX
$467M
| $3.91M | 0.49% |
+271,456
|
|
||
14
Senseonics Holdings Inc
SENS
$281M
| $59.9K | 0.01% |
+10,856
|
|
||
15
Harvard Bioscience
HBIO
$20.8M
| $7.46K | ﹤0.01% |
+11,151
|
|